Less Ads, More Data, More Tools Register for FREE

Pin to quick picksETX.L Share News (ETX)

  • There is currently no data for ETX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Bramson vehicle buys more shares in F&C

Tue, 15th Mar 2011 17:05

F&C Asset Management chairman Edward Bramson's investment vehicle SIGA LP has acquired more shares in the asset management company. Bramson was appointed chairman of F&C last month after a shareholder coup removed the previous incumbent, along with another non-executive, and appointed three new directors, including Bramson. SIGA has acquired 125,852 shares at 77.59p each. That cost £97,649 and followed the purchase of 265,000 shares at 77.79p each on Friday. SIGA has invested just over £300,000 in F&C shares in the past few days. SIGA owns around 18.1% of F&C and this is also deemed to be Bramson's holding. SIGA uses funds supplied by AIM-quoted Sherborne Investors to invest in F&C. The F&C share price has been falling back in recent weeks and it is around 10% lower over the past month. There are concerns that some asset management clients will desert F&C."Our focus now is to build on the things that work well at F&C and to improve the group's financial performance, which will create value for shareholders," according to Bramson when the company released its 2010 figures last Wednesday. A profit before tax a year ago was turned to a loss of £19.2m this time. The previous year's number benefited from a £27.9m debt exchange programme. Assets under management rose to £105.8bn from £97.8bn at the end of 2009, helped by £4.2bn from the acquisition of Thames River Capital in September. Net revenues increased to £243.2m from £225.1m, including performance related management fees of £12.9m, down from £18.7m the year before. Top Director Buys Travis Perkins (TPK) Director name: Mr Geoff CooperAmount purchased: 16,395 @ 968.19p Value: £158,735F&C Asset Management (FCAM) Director name: Mr Edward BramsonAmount purchased: 125,852 @ 77.59p Value: £97,649Travis Perkins (TPK) Director name: Mr Paul N Hampden SmithAmount purchased: 9,856 @ 968.19p Value: £95,425Travis Perkins (TPK) Director name: Mr John P CarterAmount purchased: 9,856 @ 968.19p Value: £95,425Travis Perkins (TPK) Director name: Mr Andrew PikeAmount purchased: 2,666 @ 968.19p Value: £25,812CLS Holdings (CLI) Director name: Mr H O Thomas LundqvistAmount purchased: 3,500 @ 650.00p Value: £22,750Anite (AIE) Director name: Mr David Hurst-BrownAmount purchased: 30,000 @ 65.55p Value: £19,665Anite (AIE) Director name: Mr Nigel CliffordAmount purchased: 30,000 @ 65.55p Value: £19,665e-Therapeutics (ETX) Director name: Mr Steve SelfAmount purchased: 50,000 @ 36.50p Value: £18,250Anite (AIE) Director name: Mr Richard AmosAmount purchased: 25,000 @ 65.55p Value: £16,388Top Director SellsSchroders (SDR) Director name: Mr Alan BrownAmount sold: 32,154 @ 1,734.00p Value: £557,550Prudential (PRU) Director name: Mr Mike WellsAmount sold: 31,478 @ 718.75p Value: £226,248Mondi (MNDI) Director name: Mr Peter OswaldAmount sold: 62,090 @ 553.26p Value: £343,519Novae Group (NVA) Director name: Mr Jeremy AdamsAmount sold: 65,612 @ 387.90p Value: £254,509Novae Group (NVA) Director name: Mr Oliver CorbettAmount sold: 65,612 @ 387.90p Value: £254,509Novae Group (NVA) Director name: Mr Matthew K FoshAmount sold: 65,612 @ 387.90p Value: £254,509Mondi (MNDI) Director name: Mr David A HathornAmount sold: 32,998 @ 553.26p Value: £182,565Mondi (MNDI) Director name: Mr Andrew KingAmount sold: 10,550 @ 553.26p Value: £58,369Mondi (MNDI) Director name: Ms Carol HuntAmount sold: 10,153 @ 553.26p Value: £56,172
More News
29 Oct 2019 18:49

Invesco's Holding In e-Therapeutics Drops To Zero From 32%

Invesco's Holding In e-Therapeutics Drops To Zero From 32%

Read more
7 Oct 2019 09:14

e-therapeutics Loss Narrows On Lower Costs, Collaboration Income

e-therapeutics Loss Narrows On Lower Costs, Collaboration Income

Read more
7 Oct 2019 09:13

e-therapeutics Loss Narrows On Lower Costs, New Collaboration Income

e-therapeutics Loss Narrows On Lower Costs, New Collaboration Income

Read more
13 Aug 2019 12:16

e-Therapeutics Partners With Pharma Firm For Drug Discovery

(Alliance News) - e-Therapeutics PLC on Tuesday said it has agreed to work with an undisclosed global pharmaceutical company, on a project in a specific area of biology, associated with occurs is

Read more
10 Jun 2019 13:33

Woodford Raises GBP500 Million From Flurry Of London Share Sales (ALLISS)

LONDON (Alliance News) - Over the past week, fund manager Neil Woodford's Woodford Investment Management has conducted a fire sale of its stakes in 20 London-listed companies - raising in of -

Read more
5 Mar 2019 11:50

e-Therapeutics Annual Loss Narrows Amid Reduced Research Costs

LONDON (Alliance News) - e-Therapeutics PLC on Tuesday said its annual loss narrowed as research and development costs were significantly cut.For the year ended January, the drug discovery

Read more
26 Feb 2019 16:08

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 27 February ITVFull Year ResultsRio TintoFull Year Results (at 0600 James's

Read more
10 Dec 2018 14:30

E-Therapeutics launches research collaboration with Novo Nordisk

(Sharecast News) - E-Therapeutics announced a research collaboration with Novo Nordisk on Monday, under which the two companies would use e-Therapeutics' proprietary 'Network-Driven Drug Discovery' (NDD) platform to look to discover potentially novel biological mechanisms and therapeutic approaches for a specific area of type-2 diabetes.

Read more
6 Dec 2018 16:04

E-Therapeutics and C4X upbeat on Parkinson's collaboration

(Sharecast News) - Network-driven drug discovery company e-Therapeutics and C4X Discovery Holdings updated the market on their collaboration on Thursday, to identify novel intervention strategies for the potential treatment of Parkinson's Disease (PD).

Read more
6 Dec 2018 09:23

e-Therapeutics And C4X Identify New Pathways For Parkinson's Treatment

LONDON (Alliance News) - C4X Discovery Holdings PLC and e-Therapeutics PLC on Thursday said that, through their collaboration, they discovered additional novel biological pathways for the of that

Read more
4 Oct 2018 11:08

e-Therapeutics narrows interim losses as it eyes commercial viability

(Sharecast News) - Half-year losses at e-Therapeutics have narrowed as the drug discovery and development firm continued to manage costs.

Read more
4 Oct 2018 10:31

e-Therapeutics Interim Loss Narrows As It "Carefully" Manages Costs

LONDON (Alliance News) - e-Therapeutics PLC said Thursday that its half-year loss narrowed as it continued to effectively and "carefully" manage its costs.For the six months ended

Read more
27 Sep 2018 16:16

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 28 September United UtilitiesTrading Statement Baillie Gifford Shin Year 1 events 2 3

Read more
24 May 2018 16:10

UK Shareholder Meetings Calendar - Next 7 Days

Friday 25 MayHochschild MiningFerrexpoKeywords Mutual (re managed 28 events 29 Stobart Life (re of

Read more
1 May 2018 11:41

e-Therapeutics Pens Research Collaboration With C4X Discovery

LONDON (Alliance News) - e-Therapeutics PLC and C4X Discovery Holdings PLC on Tuesday announced a research collaboration to look into insights into Parkinson's disease.The partnership,

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.